Addition
- PMID: 19626192
- PMCID: PMC2696911
- DOI: 10.3238/arztebl.2008.0500a
Addition
Comment on
-
Novel therapies in advanced renal cell carcinoma: management of adverse events from sorafenib and sunitinib.Dtsch Arztebl Int. 2008 Mar;105(13):232-7. doi: 10.3238/arztebl.2008.0232. Epub 2008 Mar 28. Dtsch Arztebl Int. 2008. PMID: 19629201 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
